United States — Food and Drug Administration & James Wilson
6 shared events · Importance 3 · Last updated Sep 30, 2025
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
United States — Food and Drug Administration: The United States — Food and Drug Administration extended the PDUFA date for Biohaven Pharmaceutical Holding Company's troriluzole new drug application and is planning an advisory committee meeting, which led to a significant drop in Biohaven Pharmaceutical Holding Company's stock price.
James Wilson: James Wilson is a Securities Litigation Partner at Faruqi & Faruqi who is encouraging investors to contact him regarding the Biohaven Pharmaceutical Holding Company class action lawsuit.
Jul 25, 2025 · 6 articles
Regulatory
James Wilson: James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Unicycive Therapeutics to contact him to discuss their legal options.
Aug 22, 2025 · 6 articles
Business
James Wilson: James Wilson, a partner at Faruqi & Faruqi, is encouraging investors who suffered losses in Telix Pharmaceuticals to contact him to discuss their legal options.
Nov 20, 2025 · 6 articles
NEWSDESK
Explore this relationship live
Track how United States — Food and Drug Administration and James Wilson interact across events, view sentiment trends, and discover connected entities.
Open Dashboard